日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Comparative efficacy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) monotherapy versus combined EGFR-TKI and chemotherapy in resectable EGFR-mutant non-small cell lung cancer: a real-world multicenter retrospective study

表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKI）单药治疗与EGFR-TKI联合化疗治疗可切除EGFR突变型非小细胞肺癌的疗效比较：一项真实世界多中心回顾性研究

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-283
Fan, Mengying; Zhao, Zerui; Yan, Wanpu; Fu, Hao; Huang, Shijie; Zhuo, Minglei; Yu, Rong; Yang, Xin; Qi, Liping; Liang, Zhen; Xiong, Hongchao; Xie, Jinbiao; Long, Hao; Chen, Ke-Neng
肺癌
肿瘤
肿瘤免疫
信号转导
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Prognosis and relapse patterns in patients with non-small cell lung cancer with pathologic complete response after neoadjuvant immunochemotherapy

新辅助免疫化疗后病理完全缓解的非小细胞肺癌患者的预后和复发模式

期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-2024-2200
Fang, Yifan; Yan, Wanpu; Zhao, Ze-Rui; Jiang, Long; Yu, Xiangyang; Yang, Xin; Yu, Zhentao; Luo, Qingquan; Long, Hao; Chen, Ke-Neng
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Effects of nutritional support during neoadjuvant therapy on perioperative outcome in esophageal cancer: a real-world cohort study

新辅助治疗期间营养支持对食管癌围手术期结局的影响：一项真实世界队列研究

期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-2025-355
Yang, Yongbo; He, Yan; Wei, Wan; Wu, Yaya; Chen, Hong; Gao, Yimei; Yan, Wanpu; Fan, Mengying; Ma, Shaohua; Liang, Zhen; Xiong, Hongchao; Dai, Liang; Chen, Ke-Neng
食管癌
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

[Application Value of Neoadjuvant Targeted Therapy in Patients with EGFR-mutant Resectable Lung Adenocarcinoma]

【新辅助靶向治疗在EGFR突变型可切除肺腺癌患者中的应用价值】

期刊:Chinese Journal of Lung Cancer
影响因子:
doi:10.3779/j.issn.1009-3419.2025.106.18
Huang, Shijie; Fan, Mengying; Peng, Kaiming; Yan, Wanpu; Chen, Boyang; Wang, Wu; Yang, Tianbao; Chen, Keneng; Kang, Mingqiang; Xie, Jinbiao
EGFR
肿瘤
EGF
肿瘤免疫
发表日期：2025
文献求助 收藏

Microenvironment-responsive metal-phenolic network release platform with ROS scavenging, anti-pyroptosis, and ECM regeneration for intervertebral disc degeneration

具有ROS清除、抗细胞焦亡和ECM再生功能的微环境响应性金属酚网络释放平台，用于治疗椎间盘退变

期刊:Bioactive Materials
影响因子:18
doi:10.1016/j.bioactmat.2024.02.036
Hao Zhou, Jinpeng He, Renfeng Liu, Jun Cheng, Yuhao Yuan, Wanpu Mao, Jun Zhou, Honghui He, Qianqi Liu, Wei Tan, Cijun Shuai, Youwen Deng
免疫
细胞生物学
其它细胞
发表日期：2024
文献求助 收藏

Osimertinib as a neoadjuvant therapy in resectable EGFR-mutant non-small cell lung cancer: a real-world, multicenter retrospective study

奥希替尼作为可切除EGFR突变型非小细胞肺癌的新辅助治疗：一项真实世界多中心回顾性研究

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-24-541
Li, Jialong; Wang, Youyu; Zhao, Zerui; Wang, Sihua; Yan, Wanpu; Chen, Xiaohui; Chen, Tianxiang; Li, Pengfei; Wang, Sheng; Fang, Qiang; Peng, Lin; Han, Yongtao; Tang, Jian; Leng, Xuefeng
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

The utility of (18)F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer

(18)F-FDG PET/CT在预测可切除非小细胞肺癌新辅助免疫化疗的病理反应和预后中的应用价值

期刊:Cancer Imaging
影响因子:3.5
doi:10.1186/s40644-024-00772-x
Guo, Rui; Yan, Wanpu; Wang, Fei; Su, Hua; Meng, Xiangxi; Xie, Qing; Zhao, Wei; Yang, Zhi; Li, Nan
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Correction: The utility of (18)F-FDG PET/CT for predicting the pathological response and prognosis to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer

更正：(18)F-FDG PET/CT 在预测可切除非小细胞肺癌新辅助免疫化疗的病理反应和预后中的应用价值

期刊:Cancer Imaging
影响因子:3.5
doi:10.1186/s40644-024-00777-6
Guo, Rui; Yan, Wanpu; Wang, Fei; Su, Hua; Meng, Xiangxi; Xie, Qing; Zhao, Wei; Yang, Zhi; Li, Nan
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Endobronchial ultrasound-guided transbronchial needle aspiration in patients with previously treated malignancies: diagnostic performance and predictive value

支气管内超声引导下经支气管针吸活检术在既往接受过治疗的恶性肿瘤患者中的诊断性能和预测价值

期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-022-02266-7
Yan, Yan; Wang, Zhilong; Yan, Wanpu; Li, Shijie; Wu, Qi
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

IGFBP1hiWNT3Alo Subtype in Esophageal Cancer Predicts Response and Prolonged Survival with PD-(L)1 Inhibitor

食管癌中的 IGFBP1hiWNT3Alo 亚型可预测 PD-(L)1 抑制剂的疗效和延长生存期

期刊:Biology-Basel
影响因子:
doi:10.3390/biology11111575
Meichen Liu, Wanpu Yan, Dongbo Chen, Jiancheng Luo, Liang Dai, Hongsong Chen, Ke-Neng Chen
信号转导
肿瘤
食管癌
FCM
IF
IHC-P
WB
Wnt/β-Catenin
IBP1
发表日期：2022
文献求助 收藏